ClinicalTrials.govpublic full text
Tracking Peripheral Blood Mononuclear Cells With Fluorine MRI
adverse reaction to diagnostic agents and kits nos, perfluorocarbon imaging, peripheral blood mononuclear cells, cancer immunotherapy, prostate cancer, mri, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 891027
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.